| 臺大學術典藏 |
2021-09-01T02:02:14Z |
Long-term hepatic consequences of chemotherapy-related HBV reactivation in lymphoma patients
|
Su W.-P.; Wen C.-C.; Hsiung C.A.; Su I.-J.; ANN-LII CHENG; Chang M.-C.; Tsao C.-J.; Kao W.-Y.; Uen W.-C.; Hsu C.-H.; Lu Y.-S.; Tien H.-F.; Chao T.-Y.; Chen L.-T.; Whang-Peng J.; Chen P.-J. |
| 臺大學術典藏 |
2021-09-01T02:02:13Z |
Phase I study of biweekly gemcitabine followed by oxaliplatin and simplified 48-h infusion of fluorouracil/leucovorin for advanced pancreatic cancer
|
Ch'ang H.-J.; Wang C.-C.; ANN-LII CHENG; Hsu C.; Lu Y.-S.; Chang M.-C.; Lin J.-T.; Wang H.-P.; Shiah H.-S.; Liu T.-W.; Chang J.-Y.; Whang-Peng J.; Chen L.-T. |
| 臺大學術典藏 |
2021-09-01T02:02:12Z |
Glucocorticoids enhance cytotoxicity of cisplatin via suppression of NF-κB activation in the glucocorticoid receptor-rich human cervical carcinoma cell line SiHa
|
Lu Y.-S.; Yeh P.-Y.; Chuang S.-E.; Gao M.; Kuo M.-L.; ANN-LII CHENG |
| 臺大學術典藏 |
2021-09-01T02:02:10Z |
Differential expression of glucocorticoid receptor in human breast tissues and related neoplasms
|
Lien H.-C.; Lu Y.-S.; ANN-LII CHENG; Chang W.-C.; Jeng Y.-M.; Kuo Y.-H.; Huang C.-S.; Chang K.-J.; Yao Y.-T. |
| 臺大學術典藏 |
2021-09-01T02:02:09Z |
Glucocorticoid receptor expression in advanced non-small cell lung cancer: clinicopathological correlation and in vitro effect of glucocorticoid on cell growth and chemosensitivity
|
Lu Y.-S.; Lien H.-C.; Yeh P.-Y.; Kuo S.-H.; Chang W.-C.; Kuo M.-L.; ANN-LII CHENG |
| 臺大學術典藏 |
2021-09-01T02:02:08Z |
Efficacy of a novel histone deacetylase inhibitor in murine models of hepatocellular carcinoma
|
Lu Y.-S.; Kashida Y.; Kulp S.K.; Wang Y.-C.; Wang D.; Hung J.-H.; Tang M.; Lin Z.-Z.; Chen T.-J.; ANN-LII CHENG; Chen C.-S. |
| 臺大學術典藏 |
2021-09-01T02:02:08Z |
A phase II trial of weekly paclitaxel and high-dose 5-fluorouracil plus leucovorin in patients with chemotherapy-pretreated metastatic breast cancer
|
Lin C.-C.; ANN-LII CHENG; Hsu C.-H.; Lu Y.-S.; Hsu C.; Yeh K.-H.; Wu C.-Y.; Huang C.-S.; Yang C.-H. |
| 臺大學術典藏 |
2021-09-01T01:54:30Z |
Differential expression of glucocorticoid receptor in carcinomas of the human digestive system
|
Lien H.-C.; Lu Y.-S.; Shun C.-T.; Yao Y.-T.; Chang W.-C.; ANN-LII CHENG |
| 臺大學術典藏 |
2021-09-01T01:54:29Z |
FTY720 induces apoptosis in hepatocellular carcinoma cells through activation of protein kinase C δ signaling
|
Hung J.-H.; Lu Y.-S.; Wang Y.-C.; Ma Y.-H.; Wang D.-S.; Kulp S.K.; Muthusamy N.; Byrd J.C.; ANN-LII CHENG; Chen C.-S. |
| 臺大學術典藏 |
2021-09-01T01:54:28Z |
Down-regulation of phospho-Akt is a major molecular determinant of bortezomib-induced apoptosis in hepatocellular carcinoma cells
|
Chen K.-F.; Yeh P.-Y.; Yeh K.-H.; Lu Y.-S.; Huang S.-Y.; ANN-LII CHENG |
| 臺大學術典藏 |
2021-09-01T01:54:27Z |
NF-κB p50 promotes tumor cell invasion through negative regulation of invasion suppressor gene CRMP-1 in human lung adenocarcinoma cells
|
Gao M.; Yeh P.Y.; Lu Y.-S.; Chang W.C.; Kuo M.-L.; ANN-LII CHENG |
| 臺大學術典藏 |
2021-09-01T01:54:26Z |
OSU-03012, a novel celecoxib derivative, induces reactive oxygen species-related autophagy in hepatocellular carcinoma
|
Gao M.; Yeh P.Y.; Lu Y.-S.; Hsu C.-H.; Chen K.-F.; Lee W.-C.; Feng W.-C.; Chen C.-S.; Kuo M.-L.; ANN-LII CHENG |
| 臺大學術典藏 |
2021-09-01T01:54:22Z |
Bortezomib overcomes tumor necrosis factor-related apoptosis-inducing ligand resistance in hepatocellular carcinoma cells in part through the inhibition of the phosphatidylinositol 3-kinase/Akt pathway
|
Chen K.-F.; Yeh P.-Y.; Hsu C.; Hsu C.-H.; Lu Y.-S.; Hsieh H.-P.; Chen P.-J.; ANN-LII CHENG |
| 臺大學術典藏 |
2021-09-01T01:54:21Z |
Molecular subtypes of breast cancer emerging in young women in Taiwan: Evidence for more than just westernization as a reason for the disease in Asia
|
Lin C.-H.; Liau J.-Y.; Lu Y.-S.; Huang C.-S.; Lee W.-C.; Kuo K.-T.; Shen Y.-C.; Kuo S.-H.; Lan C.; Liu J.M.; Kuo W.-H.; Chang K.-J.; ANN-LII CHENG |
| 臺大學術典藏 |
2021-09-01T01:54:19Z |
Induction of Bim expression contributes to the antitumor synergy between sorafenib and mitogen-activated protein kinase/extracellular signal-regulated kinase kinase inhibitor CI-1040 in hepatocellular carcinoma
|
Ou D.-L.; Shen Y.-C.; Liang J.-D.; Liou J.-Y.; Yu S.-L.; Fan H.-H.; Wang D.-S.; Lu Y.-S.; Hsu C.; ANN-LII CHENG |
| 臺大學術典藏 |
2021-09-01T01:54:18Z |
Fractionated evaluation of immunohistochemical hormone receptor expression enhances prognostic prediction in breast cancer patients treated with tamoxifen as adjuvant therapy
|
Lin C.-H.; Lien H.-C.; Hu F.-C.; Lu Y.-S.; Kuo S.-H.; Wu L.-C.; You S.-L.; ANN-LII CHENG; Chang K.-J.; Huang C.-S. |
| 臺大學術典藏 |
2021-09-01T01:54:16Z |
Predictive and prognostic values of tau and ERCC1 in advanced breast cancer patients treated with paclitaxel and cisplatin
|
Shao Y.-Y.; Kuo K.-T.; Hu F.-C.; Lu Y.-S.; Huang C.-S.; Liau J.-Y.; Lee W.-C.; Hsu C.; Kuo W.-H.; Chang K.-J.; Lin C.-H.; ANN-LII CHENG |
| 臺大學術典藏 |
2021-09-01T01:54:14Z |
Vinorelbine plus 24-hour infusion of high-dose 5-fluorouracil and leucovorin as effective palliative chemotherapy for breast cancer patients with acute disseminated intravascular coagulation
|
Lin P.-H.; Lu Y.-S.; Lin C.-H.; Chang D.-Y.; Huang C.-S.; ANN-LII CHENG; Yeh K.-H. |
| 臺大學術典藏 |
2021-09-01T01:54:14Z |
O6-Methylguanine-DNA methyltransferase expression and prognostic value in brain metastases of lung cancers
|
Wu P.-F.; Kuo K.-T.; Kuo L.-T.; Lin Y.-T.; Lee W.-C.; Lu Y.-S.; Yang C.-H.; Wu R.-M.; Tu Y.-K.; Tasi J.-C.; Tseng H.-M.; Tseng S.-H.; ANN-LII CHENG; Lin C.-H. |
| 臺大學術典藏 |
2021-09-01T01:54:11Z |
Combinations of mTORC1 inhibitor RAD001 with gemcitabine and paclitaxel for treating non-Hodgkin lymphoma
|
Chiang C.-T.; Yeh P.-Y.; Gao M.; Chen C.-W.; Yeh L.-C.; Feng W.-C.; Kuo S.-H.; Hsu C.-H.; Lu Y.-S.; ANN-LII CHENG |
| 臺大學術典藏 |
2021-09-01T01:54:08Z |
IκB kinases increase Myc protein stability and enhance progression of breast cancer cells
|
Yeh P.-Y.; Lu Y.-S.; Ou D.-L.; ANN-LII CHENG |
| 臺大學術典藏 |
2021-09-01T01:54:08Z |
Lack of compensatory pAKT activation and eIF4E phosphorylation of lymphoma cells towards mTOR inhibitor, RAD001
|
Kuo S.-H.; Hsu C.-H.; Chen L.-T.; Lu Y.-S.; Lin C.-H.; Yeh P.-Y.; Jeng H.-J.; Gao M.; Yeh K.-H.; ANN-LII CHENG |
| 臺大學術典藏 |
2021-09-01T01:54:07Z |
Prognostic molecular markers in Women aged 35 years or younger with breast cancer: Is there a difference from the older patients?
|
Lin C.-H.; Lu Y.-S.; Huang C.-S.; Kuo K.-T.; Wang C.-C.; You S.-L.; Lin P.-H.; Chang D.-Y.; Kuo W.-H.; Chang K.-J.; ANN-LII CHENG |
| 臺大學術典藏 |
2021-09-01T01:54:05Z |
Lack of efficacy to systemic chemotherapy for treatment of metaplastic carcinoma of the breast in the modern era
|
Chen I.C.; Lin C.H.; Huang C.S.; Lien H.C.; Hsu C.; Kuo W.H.; Lu Y.S.; ANN-LII CHENG |
| 臺大學術典藏 |
2021-09-01T01:54:02Z |
Multimodel assessment of BRCA1 mutations in Taiwanese (ethnic Chinese) women with early-onset, bilateral or familial breast cancer
|
Kuo W.-H.; Lin P.-H.; Huang A.-C.; Chien Y.-H.; Liu T.-P.; Lu Y.-S.; Bai L.-Y.; Sargeant A.M.; Lin C.-H.; ANN-LII CHENG; Hsieh F.-J.; Hwu W.-L.; Chang K.-J. |
| 臺大學術典藏 |
2021-09-01T01:54:02Z |
Efficacy, safety, and potential biomarkers of thalidomide plus metronomic chemotherapy for advanced hepatocellular carcinoma
|
Shao Y.-Y.; Lin Z.-Z.; Hsu C.; Lee K.-D.; Hsiao C.-H.; Lu Y.-S.; Huang C.-C.; Shen Y.-C.; Hsu C.-H.; ANN-LII CHENG |
| 臺大學術典藏 |
2021-09-01T01:54:01Z |
The impact of diabetes mellitus on prognosis of early breast cancer in Asia
|
Chen W.-W.; Shao Y.-Y.; Shau W.-Y.; Lin Z.-Z.; Lu Y.-S.; Chen H.-M.; Kuo R.N.C.; ANN-LII CHENG; Lai M.-S. |
| 臺大學術典藏 |
2021-09-01T01:54:00Z |
The emerging epidemic of estrogen-related cancers in young women in a developing Asian country
|
Lin C.-H.; Chen Y.-C.; Chiang C.-J.; Lu Y.-S.; Kuo K.-T.; Huang C.-S.; Cheng W.-F.; Lai M.-S.; You S.-L.; ANN-LII CHENG |
| 臺大學術典藏 |
2021-09-01T01:53:59Z |
Radiosensitizing effect of a phenylbutyrate-derived histone deacetylase inhibitor in hepatocellular carcinoma
|
Lu Y.-S.; Chou C.-H.; Tzen K.-Y.; Gao M.; ANN-LII CHENG; Kulp S.K.; Cheng J.C.-H. |
| 臺大學術典藏 |
2021-09-01T01:53:55Z |
Dynamics of circulating endothelial cells and endothelial progenitor cells in breast cancer patients receiving cytotoxic chemotherapy
|
Kuo Y.-H.; Lin C.-H.; Shau W.-Y.; Chen T.-J.; Yang S.-H.; Huang S.-M.; Hsu C.; Lu Y.-S.; ANN-LII CHENG |
| 臺大學術典藏 |
2021-09-01T01:53:53Z |
The first two lines of chemotherapy for anthracycline-naive metastatic breast cancer: A comparative study of the efficacy of anthracyclines and non-anthracyclines
|
Chen W.-W.; Chang D.-Y.; Huang S.-M.; Lin C.-H.; Hsu C.; Lin M.-H.; Huang C.-S.; Lu Y.-S.; ANN-LII CHENG |
| 臺大學術典藏 |
2021-09-01T01:53:50Z |
Clinical significance of ESR1 gene copy number changes in breast cancer as measured by fluorescence in situ hybridisation
|
Lin C.-H.; Liu J.M.; Lu Y.-S.; Lan C.; Lee W.-C.; Kuo K.-T.; Wang C.-C.; Chang D.-Y.; Huang C.-S.; ANN-LII CHENG |
| 臺大學術典藏 |
2021-09-01T01:53:45Z |
Phosphorylated insulin-like growth factor-1 receptor (pIGF1R) is a poor prognostic factor in brain metastases from lung adenocarcinomas
|
Wu P.-F.; Huang W.-C.; Yang J.C.-H.; Lu Y.-S.; Shih J.-Y.; Wu S.-G.; Lin C.-H.; ANN-LII CHENG |
| 臺大學術典藏 |
2021-09-01T01:53:43Z |
CYP19 genetic polymorphism haplotype aasa is associated with a poor prognosis in premenopausal women with lymph node-negative, hormone receptor-positive breast cancer
|
Kuo S.-H.; Yang S.-Y.; Lien H.-C.; Lo C.; Lin C.-H.; Lu Y.-S.; ANN-LII CHENG; Chang K.-J.; Huang C.-S. |
| 臺大學術典藏 |
2021-09-01T01:53:40Z |
Distinct clinicopathological features and prognosis of emerging young-female breast cancer in an east Asian country: A nationwide cancer registry-based study
|
Lin C.-H.; Chuang P.-Y.; Chiang C.-J.; Lu Y.-S.; ANN-LII CHENG; Kuo W.-H.; Huang C.-S.; Lai M.-S.; You S.-L.; Tang C.-H. |
| 臺大學術典藏 |
2021-08-31T06:42:25Z |
No increased venous thromboembolism risk in Asian breast cancer patients receiving adjuvant tamoxifen
|
Chen T.W.-W.; Chen H.-M.; Lin C.-H.; Huang C.-S.; ANN-LII CHENG; Lai M.-S.; Lu Y.-S. |
| 臺大學術典藏 |
2021-08-31T06:42:22Z |
A phase i study of two dosing schedules of volasertib (BI 6727), an intravenous polo-like kinase inhibitor, in patients with advanced solid malignancies
|
Lin C.-C.; Su W.-C.; Yen C.-J.; Hsu C.-H.; Su W.-P.; Yeh K.-H.; Lu Y.-S.; ANN-LII CHENG; Huang D.C.-L.; Fritsch H.; Voss F.; Taube T.; Yang J.C.-H. |
| 臺大學術典藏 |
2021-08-31T06:29:51Z |
A pilot study of bevacizumab combined with etoposide and cisplatin in breast cancer patients with leptomeningeal carcinomatosis
|
Wu P.-F.; Lin C.-H.; Kuo C.-H.; Chen W.-W.; Yeh D.-C.; Liao H.-W.; Huang S.-M.; ANN-LII CHENG; Lu Y.-S. |
| 臺大學術典藏 |
2021-08-31T06:29:51Z |
Bevacizumab preconditioning followed by etoposide and cisplatin is highly effective in treating brain metastases of breast cancer progressing from whole-brain radiotherapy
|
Lu Y.-S.; Chen T.W.-W.; Lin C.-H.; Yeh D.-C.; Tseng L.-M.; Wu P.-F.; Rau K.-M.; Chen B.-B.; Chao T.-C.; Huang S.-M.; Huang C.-S.; Shih T.T.-F.; ANN-LII CHENG; Taiwan Breast Cancer Consortium |
| 臺大學術典藏 |
2021-08-31T06:29:50Z |
High prevalence of the BIM deletion polymorphism in young female breast cancer in an East Asian country
|
Lin C.-H.; Shen C.-Y.; Lee J.-H.; Huang C.-S.; Yang C.-H.; Kuo W.-H.; Chang D.-Y.; Hsiung C.-N.; Kuo K.-T.; Chen W.-W.; Chen I.-C.; Wu P.-F.; Kuo S.-H.; Chen C.-J.; Lu Y.-S.; ANN-LII CHENG |
| 臺大學術典藏 |
2021-08-31T06:29:46Z |
TP53 Mutational Analysis Enhances the Prognostic Accuracy of IHC4 and PAM50 Assays
|
Lin C.-H.; Chen I.-C.; Huang C.-S.; Hu F.-C.; Kuo W.-H.; Kuo K.-T.; Wang C.-C.; Wu P.-F.; Chang D.-Y.; Wang M.-Y.; Chang C.-H.; Chen W.-W.; Lu Y.-S.; ANN-LII CHENG |
| 臺大學術典藏 |
2021-08-31T06:29:45Z |
Clinical Relevance of Liver Kinase B1(LKB1) Protein and Gene Expression in Breast Cancer
|
Chen I.-C.; Chang Y.-C.; Lu Y.-S.; Chung K.-P.; Huang C.-S.; Lu T.-P.; Kuo W.-H.; Wang M.-Y.; Kuo K.-T.; Wu P.-F.; Hsueh T.-H.; Shen C.-Y.; Lin C.-H.; ANN-LII CHENG |
| 臺大學術典藏 |
2021-08-31T06:29:44Z |
Bevacizumab might potentiate the chemotherapeutic effect in breast cancer patients with leptomeningeal carcinomatosis
|
Chen I.-C.; Lin C.-H.; Jan I.-S.; ANN-LII CHENG; Lu Y.-S. |
| 臺大學術典藏 |
2021-08-31T06:29:43Z |
A pilot study to determine the timing and effect of bevacizumab on vascular normalization of metastatic brain tumors in breast cancer
|
Chen B.-B.; Lu Y.-S.; Lin C.-H.; Chen W.-W.; Wu P.-F.; Hsu C.-Y.; Yu C.-W.; Wei S.-Y.; ANN-LII CHENG; Shih T.T.-F. |
| 臺大學術典藏 |
2021-08-31T06:29:42Z |
Locoregional Recurrence Risk for Postmastectomy Breast Cancer Patients With T1�V2 and One to Three Positive Lymph Nodes Receiving Modern Systemic Treatment Without Radiotherapy
|
Lai S.-F.; Chen Y.-H.; Kuo W.-H.; Lien H.-C.; Wang M.-Y.; Lu Y.-S.; Lo C.; Kuo S.-H.; ANN-LII CHENG; Huang C.-S. |
| 臺大學術典藏 |
2021-08-31T06:29:33Z |
Phosphatidylinositol-3 Kinase Inhibitors, Buparlisib and Alpelisib, Sensitize Estrogen Receptor-positive Breast Cancer Cells to Tamoxifen
|
Chen I.-C.; Hsiao L.-P.; Huang I.-W.; Yu H.-C.; Yeh L.-C.; Lin C.-H.; Wei-Wu Chen T.; ANN-LII CHENG; Lu Y.-S. |
| 臺大學術典藏 |
2021-08-31T06:29:30Z |
A Phase I/II study of the combination of lapatinib and oral vinorelbine in HER2-positive metastatic breast cancer
|
Chen T.W.-W.; Yeh D.-C.; Chao T.-Y.; Lin C.-H.; Chow L.W.-C.; Chang D.-Y.; Hsieh Y.-Y.; Huang S.-M.; ANN-LII CHENG; Lu Y.-S.; Taiwan Breast Cancer Consortium |
| 臺大學術典藏 |
2021-08-31T06:29:29Z |
Adiposity, inflammation, and breast cancer pathogenesis in Asian Women
|
Iyengar N.M.; Chen I.-C.; Zhou X.K.; Giri D.D.; Falcone D.J.; Winston L.A.; Wang H.; Williams S.; Lu Y.-S.; Hsueh T.-H.; ANN-LII CHENG; Hudis C.A.; Lin C.-H.; Dannenberg A.J. |
| 臺大學術典藏 |
2021-08-31T06:29:27Z |
Effect of glucocorticoid use on survival in patients with stage I�VIII breast cancer
|
Lin C.-H.; Chuang P.-Y.; You S.-L.; Chiang C.-J.; Huang C.-S.; Wang M.-Y.; Chao M.; Lu Y.-S.; ANN-LII CHENG; Tang C.-H. |
| 臺大學術典藏 |
2021-08-31T06:29:25Z |
Imaging biomarkers from multiparametric magnetic resonance imaging are associated with survival outcomes in patients with brain metastases from breast cancer
|
Chen B.-B.; Lu Y.-S.; Yu C.-W.; Lin C.-H.; Chen T.W.-W.; Wei S.-Y.; ANN-LII CHENG; Shih T.T.-F. |
